Marketplaces like Amazon, HSN, and QVC give beauty and personal care sellers fast access to millions of shoppers. But they also set their own testing, documentation, and claims requirements that sit on top of FDA’s.
The regulatory bar has moved too. Under the Modernization of Cosmetics Regulation Act (MoCRA), the responsible person, meaning the manufacturer, packer, or distributor named on the label, must keep records showing adequate substantiation of safety for every cosmetic product. For many third-party sellers, that responsible person is them.
Most listing delays and takedowns trace back to a small set of avoidable testing mistakes or omissions. Here are five to watch for.
1. Taking the Supplier’s Paperwork at Face Value
Many private-label and import sellers launch based on a Certificate of Analysis (COA) or spec sheet from their contract manufacturer. That document may be accurate. It may also describe a different batch, a different formula, or tests run by a lab no one has vetted.
The risk is real. FDA testing of imported gel nail polish removers in 2024 and 2025 found methylene chloride, an ingredient banned in cosmetics at any level, in products that did not list it on the label. Testing was the only way it surfaced.
Legal analysts also caution that existing literature or generic data should not be assumed to stand in for product-specific testing under MoCRA’s safety substantiation standard.
What to do instead: Treat supplier documentation as a starting point. Verify it with independent testing of your own finished product, and confirm the COA names the methods used and the lab that performed them.
2. Testing for Contamination but Not Preservative Performance
Microbial limits testing confirms a batch is free of harmful bacteria, yeast, and mold at the time of testing. Many retailers require it, and it typically screens for specified organisms such as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans.
What it does not show is whether the product stays clean after a customer opens it, dips fingers in it, and stores it in a humid bathroom for months. Antimicrobial preservative effectiveness testing challenges the formula with organisms and measures whether the preservative system keeps them in check over time.
Water-based products, products with natural or “preservative-free” positioning, and anything used near the eyes carry the most risk here.
What to do instead: Pair microbial limits testing with preservative effectiveness testing before launch, and repeat microbial testing on each production batch.
3. Writing the Listing Before the Data Exists
On a crowded marketplace, claims sell. “Hypoallergenic,” “dermatologist-tested,” “non-irritating,” and “clinically shown to hydrate” all help a product stand out, but each one is a promise that needs evidence behind it.
HSN expects claims such as “anti-aging” or “moisturizing” to be backed by scientific data, and QVC expects organic, cruelty-free, and hypoallergenic claims to carry third-party verification. Even soft terms carry weight: class action plaintiffs often argue that words like “non-toxic” or “all natural” imply a product is safe.
Some claims also change what the product is. A sun protection claim, for example, brings a sunscreen into OTC drug territory, with its own required testing.
What to do instead: Build the claims list first, then match each claim to the study that supports it (patch testing, clinical efficacy, SPF, or in vitro safety work) before any listing goes live.
4. Treating Testing as a One-Time Launch Task
A product that passed testing at launch is not automatically the product on the shelf a year later. Sellers often swap manufacturers to cut costs, reformulate around an ingredient shortage, or move to new packaging, and keep relying on the original results.
Each change can affect safety and stability. New packaging can interact with the formula, and a new manufacturer brings a new process and new contamination risks. MoCRA also requires product listings to be updated when product information changes, so the paperwork and the product need to stay in step.
QVC expects batch-level testing to ensure consistent quality and safety, and stability and compatibility testing helps a seller support shelf-life and packaging decisions.
What to do instead: Set retest triggers in advance: a new manufacturer, a formula change, new packaging, or a new claim should each prompt a review of which tests need to be repeated.
5. Choosing a Lab on Price and Speed Alone
A fast, inexpensive test report only has value if reviewers accept it. Retail compliance teams, regulators, and platforms look at who ran the test and how, not just the result.
For some product categories, platforms now name the labs they will accept. Amazon, for example, requires dietary supplement sellers to work through an approved third-party testing, inspection, and certification (TIC) provider, and results from non-approved labs must be revalidated by an approved provider at added cost.
What to do instead: Before booking testing, check what your destination platform requires, then look for ISO/IEC 17025 accreditation, FDA registration, validated methods, and in-house expertise to help you decide which tests your product actually needs.
Get Marketplace-Ready With CPT℠ Labs
Testing is what keeps a listing live, not just what gets it approved. CPT℠ Labs is an ISO/IEC 17025-accredited, FDA-registered contract testing laboratory supporting cosmetic and personal care brands with microbiology, preservative effectiveness, stability, clinical safety, claims substantiation, and in vitro toxicology testing, plus consulting to build a testing program around your product and platform.
Request a quote today, or explore our Third-Party Seller Testing and Consulting service.